Abstract
Bmi1 is a polycomb group protein and regulator that stabilizes the ubiquitination complex PRC1 in the nucleus with no evidently direct link to the NF-κB pathway. In this study, we report a novel function of Bmi1: its regulation of IκBα ubiquitination in the cytoplasm. A deficiency of Bmi1 inhibited NF-κB-mediated gene expression in vitro and a NF-κB-mediated mouse model of arthritis in vivo. Mechanistic analysis showed that Bmi1 associated with the SCF ubiquitination complex via its N terminus and with phosphorylation by an IKKα/β-dependent pathway, leading to the ubiquitination of IκBα. These effects on NF-κB-related inflammation suggest Bmi1 in the SCF complex is a potential therapeutic target for various diseases and disorders, including autoimmune diseases.
Copyright © 2018 by The American Association of Immunologists, Inc.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Arthritis, Experimental / metabolism*
-
Arthritis, Rheumatoid / metabolism*
-
Cells, Cultured
-
Cytoplasm / metabolism*
-
Endothelial Cells / physiology*
-
Humans
-
Mice
-
Mice, Inbred C57BL
-
Multiprotein Complexes / genetics
-
Multiprotein Complexes / metabolism*
-
NF-KappaB Inhibitor alpha / metabolism*
-
NF-kappa B / metabolism
-
Polycomb Repressive Complex 1 / genetics
-
Polycomb Repressive Complex 1 / metabolism*
-
Protein Binding
-
Protein Stability
-
Proteolysis
-
Proto-Oncogene Proteins / genetics
-
Proto-Oncogene Proteins / metabolism*
-
RNA, Small Interfering / genetics
-
SKP Cullin F-Box Protein Ligases / genetics
-
SKP Cullin F-Box Protein Ligases / metabolism*
-
Transcriptional Activation
-
Ubiquitination
Substances
-
Bmi1 protein, mouse
-
Multiprotein Complexes
-
NF-kappa B
-
Proto-Oncogene Proteins
-
RNA, Small Interfering
-
NF-KappaB Inhibitor alpha
-
Polycomb Repressive Complex 1
-
SKP Cullin F-Box Protein Ligases